• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卒中相关性肺炎患者的细菌学特征及病原体的药敏分析:一项横断面研究

Bacteriological Profile of Patients With Stroke-Associated Pneumonia and Antimicrobial Susceptibility of Pathogens: A Cross-Sectional Study.

作者信息

Mohapatra Smrutisree, Pathi Basanti Kumari, Mohapatra Ipsa, Singh Nipa, Sahoo Jyoti Prakash, Das Narendra Kumar, Pattnaik Dipti

机构信息

Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.

Community Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.

出版信息

Cureus. 2024 Nov 21;16(11):e74150. doi: 10.7759/cureus.74150. eCollection 2024 Nov.

DOI:10.7759/cureus.74150
PMID:39712707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663042/
Abstract

BACKGROUND AND OBJECTIVES

Stroke-associated pneumonia (SAP) is the aftermath of aspiration of oropharyngeal secretions or stomach content. Mechanical ventilation and lowered immunity and consciousness facilitate the etiopathogenesis of SAP. Antibiotic prophylaxis and repeated culture and sensitivity testing dampen the drug susceptibility patterns of the pathogens. We accomplished this study to determine the bacteriological profile of patients with SAP and the antimicrobial susceptibility patterns of the pathogenic bacteria.

METHODS

This cross-sectional study was executed from August 2022 to May 2024 at Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India. We included adult patients who endured treatment in the neurosurgery intensive care unit (ICU) throughout the study period due to a stroke and developed pneumonia within 48 hours of admission. The endotracheal tube (ET) aspirate and bronchoalveolar lavage (BAL) fluid specimens collected from the eligible participants were analyzed. Enriched and selective media such as 5% sheep blood agar, chocolate agar, and MacConkey agar were used to culture pathogenic bacteria. The VITEK 2 system was used to identify isolates and assess antimicrobial susceptibility testing (AST). The pathogenic bacteria and their antimicrobial susceptibility patterns were gauged. We leveraged R software (version 4.4.1) for data analysis.

RESULTS

Two hundred forty bacterial isolates were found in the 181 eligible patients. Forty-eight (26.52%) participants were females. The median age of the study population was 64.50 (58.74-70.24) years. Fifty-nine (32.60%) participants had two different isolates in their culture reports. We found the following non-fermenters: (55, 22.92%), (31, 12.92%), (6, 2.50%), and (4, 1.67%). (88, 36.67%) and (15, 6.25%) were the most commonly noticed Enterobacterales. Other Enterobacterales were (9, 3.75%), (8, 3.33%), (3, 1.25%), (1, 0.42%), (1, 0.42%), and complex (5, 2.08%). (14, 5.83%) was the only gram-positive cocci in our study population. The sensitivity of was maximum for minocycline. was highly sensitive to imipenem and completely resistant to tigecycline. Minocycline was the only effective drug against . Similarly, the Enterobacterales had the greatest sensitivity for tigecycline. All 14 specimens of were sensitive to both vancomycin and linezolid. They were responsive to tigecycline as well.

CONCLUSION

The most common pathogenic bacteria in our study were , , , , and . Enterobacterales were highly sensitive to tigecycline. and had maximum sensitivity for minocycline. All isolates of were sensitive to both vancomycin and linezolid. We warrant further research with a larger sample size to investigate the bacteriological profile among other critically ill patients and their AST findings.

摘要

背景与目的

卒中相关性肺炎(SAP)是口咽分泌物或胃内容物误吸的后果。机械通气以及免疫力和意识降低促进了SAP的发病机制。抗生素预防以及反复的培养和药敏试验会影响病原体的药敏模式。我们开展这项研究以确定SAP患者的细菌学特征以及病原菌的抗菌药敏模式。

方法

这项横断面研究于2022年8月至2024年5月在印度布巴内斯瓦尔的加林加医学科学研究所(KIMS)进行。我们纳入了在整个研究期间因卒中在神经外科重症监护病房(ICU)接受治疗且在入院后48小时内发生肺炎的成年患者。对从符合条件的参与者收集的气管内导管(ET)吸出物和支气管肺泡灌洗(BAL)液标本进行分析。使用5%羊血琼脂、巧克力琼脂和麦康凯琼脂等富集和选择性培养基培养病原菌。采用VITEK 2系统鉴定分离株并评估抗菌药敏试验(AST)。评估病原菌及其抗菌药敏模式。我们利用R软件(版本4.4.1)进行数据分析。

结果

在181名符合条件的患者中发现了240株细菌分离株。48名(26.52%)参与者为女性。研究人群的中位年龄为64.50(58.74 - 70.24)岁。59名(32.60%)参与者在其培养报告中有两种不同的分离株。我们发现了以下非发酵菌:(55株,22.92%),(31株,12.92%),(6株,2.50%),以及(4株,1.67%)。(88株,36.67%)和(15株,6.25%)是最常见的肠杆菌科细菌。其他肠杆菌科细菌有(9株,3.75%),(8株,3.33%),(3株,1.25%),(1株,0.42%),(1株,0.42%),以及复合体(5株,2.08%)。(14株,5.83%)是我们研究人群中唯一的革兰氏阳性球菌。对米诺环素的敏感性最高。对亚胺培南高度敏感,对替加环素完全耐药。米诺环素是针对的唯一有效药物。同样,肠杆菌科细菌对替加环素的敏感性最高。所有14株的标本对万古霉素和利奈唑胺均敏感。它们对替加环素也有反应。

结论

我们研究中最常见的病原菌是、、、、和。肠杆菌科细菌对替加环素高度敏感。和对米诺环素的敏感性最高。所有分离株对万古霉素和利奈唑胺均敏感。我们需要进行更大样本量的进一步研究,以调查其他重症患者的细菌学特征及其AST结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/e64654dcecdd/cureus-0016-00000074150-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/7363f1ff6532/cureus-0016-00000074150-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/5bef6520d6f9/cureus-0016-00000074150-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/04a8d61a6805/cureus-0016-00000074150-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/a0528fe98279/cureus-0016-00000074150-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/54c904f3c64a/cureus-0016-00000074150-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/b9b3b68ef09f/cureus-0016-00000074150-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/a0593ffea65a/cureus-0016-00000074150-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/e64654dcecdd/cureus-0016-00000074150-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/7363f1ff6532/cureus-0016-00000074150-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/5bef6520d6f9/cureus-0016-00000074150-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/04a8d61a6805/cureus-0016-00000074150-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/a0528fe98279/cureus-0016-00000074150-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/54c904f3c64a/cureus-0016-00000074150-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/b9b3b68ef09f/cureus-0016-00000074150-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/a0593ffea65a/cureus-0016-00000074150-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f28f/11663042/e64654dcecdd/cureus-0016-00000074150-i08.jpg

相似文献

1
Bacteriological Profile of Patients With Stroke-Associated Pneumonia and Antimicrobial Susceptibility of Pathogens: A Cross-Sectional Study.卒中相关性肺炎患者的细菌学特征及病原体的药敏分析:一项横断面研究
Cureus. 2024 Nov 21;16(11):e74150. doi: 10.7759/cureus.74150. eCollection 2024 Nov.
2
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.中国革兰阳性和革兰阴性菌中头孢洛林、头孢他啶-阿维巴坦和对照药物的体外活性:2018 年 ATLAS 项目的结果。
BMC Microbiol. 2022 Oct 1;22(1):234. doi: 10.1186/s12866-022-02644-5.
3
[An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].[2011年13所教学医院医院感染病原菌耐药性分析]
Zhonghua Nei Ke Za Zhi. 2013 Mar;52(3):203-12.
4
[Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].[2011年、2013年和2016年医院获得性菌血症病原菌的微生物学特征]
Sheng Wu Gong Cheng Xue Bao. 2018 Aug 25;34(8):1205-1217. doi: 10.13345/j.cjb.180192.
5
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.替加环素评估和监测试验;评估替加环素和其他选定抗生素对 2004 年至 2016 年期间从法国收集的革兰氏阳性和革兰氏阴性病原体的活性。
Antimicrob Resist Infect Control. 2018 May 30;7:68. doi: 10.1186/s13756-018-0360-y. eCollection 2018.
6
Analysis of cumulative antibiogram reports in intensive care units at an Egyptian University Hospital.埃及大学附属医院重症监护病房累积药敏报告分析。
J Infect Public Health. 2023 Aug;16(8):1220-1229. doi: 10.1016/j.jiph.2023.05.032. Epub 2023 May 30.
7
Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.美国革兰氏阴性菌和革兰氏阳性菌的抗菌药敏率最新情况:2005年至2007年替加环素评估与监测试验(TEST)结果
Clin Ther. 2008 Nov;30(11):2040-50. doi: 10.1016/j.clinthera.2008.11.006.
8
Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran; evaluation of biofilm production and molecular typing of bacterial isolates.从伊朗西南部医院获得性肺炎患者中鉴定和检测致病菌;评估细菌分离物的生物膜生成和分子分型。
BMC Pulm Med. 2021 Dec 9;21(1):408. doi: 10.1186/s12890-021-01773-3.
9
Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.2012-2016 年间收集的革兰氏阳性和革兰氏阴性血源性病原体的抗菌药敏性,作为替加环素评估和监测试验的一部分。
Antimicrob Resist Infect Control. 2018 Dec 13;7:152. doi: 10.1186/s13756-018-0441-y. eCollection 2018.
10
Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.2004 年至 2009 年期间,作为替加环素评估和监测试验的一部分,在北美、欧洲、亚太地区、拉丁美洲、中东和非洲的重症监护病房收集的革兰氏阴性分离物的抗菌药敏性。
Clin Ther. 2012 Jan;34(1):124-37. doi: 10.1016/j.clinthera.2011.11.023. Epub 2011 Dec 9.

本文引用的文献

1
Bacterial stroke-associated pneumonia: microbiological analysis and mortality outcome.细菌性卒中相关性肺炎:微生物学分析与死亡率结局。
BMC Neurol. 2024 Jul 30;24(1):265. doi: 10.1186/s12883-024-03755-4.
2
Clinical Characteristics and Risk Factors for Infection and Death in Critically Ill Patients with Pulmonary Infection with Spp.肺部感染患者合并 菌感染的危重症患者感染及死亡的临床特征和危险因素
Infect Drug Resist. 2024 Jun 27;17:2673-2683. doi: 10.2147/IDR.S460640. eCollection 2024.
3
Risk Factors for the Development of Pneumonia in Stroke Patients: A Systematic Review and Meta-Analysis.
中风患者发生肺炎的危险因素:系统评价与Meta分析
Cureus. 2024 Mar 27;16(3):e57077. doi: 10.7759/cureus.57077. eCollection 2024 Mar.
4
Clinical manifestations, antimicrobial resistance and genomic feature analysis of multidrug-resistant Elizabethkingia strains.多重耐药伊丽莎白菌的临床特征、耐药性分析和基因组特征分析。
Ann Clin Microbiol Antimicrob. 2024 Apr 10;23(1):32. doi: 10.1186/s12941-024-00691-6.
5
Prognostic factors of poor outcomes in pneumonia in older adults: aspiration or frailty?老年人肺炎不良预后的预测因素:吸入还是衰弱?
Eur Geriatr Med. 2024 Apr;15(2):481-488. doi: 10.1007/s41999-023-00929-0. Epub 2024 Feb 3.
6
Factors associated with an increased risk of developing pneumonia during acute ischemic stroke hospitalization.与急性缺血性脑卒中住院期间发生肺炎风险增加相关的因素。
PLoS One. 2024 Jan 10;19(1):e0296938. doi: 10.1371/journal.pone.0296938. eCollection 2024.
7
Post-stroke immunosuppression: Exploring potential implications beyond infections.卒中后免疫抑制:探索感染之外的潜在影响。
Eur J Neurosci. 2023 Dec;58(11):4269-4281. doi: 10.1111/ejn.16174. Epub 2023 Oct 19.
8
The diagnosis of aspiration pneumonia in older persons: a systematic review.老年人吸入性肺炎的诊断:系统评价。
Eur Geriatr Med. 2022 Oct;13(5):1071-1080. doi: 10.1007/s41999-022-00689-3. Epub 2022 Aug 25.
9
Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study.在埃塞俄比亚西北部贡德尔的成年社区获得性肺炎患者中,细菌谱、抗菌药物敏感性模式以及相关因素的横断面研究。
PLoS One. 2022 Feb 1;17(2):e0262956. doi: 10.1371/journal.pone.0262956. eCollection 2022.
10
Microbiology and Outcomes of Institutionalized Patients With Stroke-Associated Pneumonia: An Observational Cohort Study.机构化卒中相关性肺炎患者的微生物学特征与转归:一项观察性队列研究
Front Microbiol. 2021 Dec 3;12:720051. doi: 10.3389/fmicb.2021.720051. eCollection 2021.